Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Finasteride and dutasteride have limited use in feminising therapy and are not recommended for routine use.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Dutasteride may reduce insulin sensitivity and increase body fat.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

5-alpha reductase inhibitors like finasteride and dutasteride are effective for treating enlarged prostate and male pattern hair loss.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.